SuperX
  1. Home
  2. Stocks
  3. FEROZ
  4. Peers

FEROZ · PHARMACEUTICALS

FEROZ against its peers Ferozsons Laboratories Limited

Ferozsons Laboratories Limited (FEROZ) is set against 10 peers in the PHARMACEUTICALS sector. By market value it ranks 8 of 11.

PHARMACEUTICALS peers on one table

CompanyLast close (Rs)Place in the 52-week rangeMarket valuePrice per rupee earned (12 months)
GLAXO332.0225%Rs 105.7 bn9.63
ABOT1,013.2842%Rs 99.2 bn10.68
HALEON687.7311%Rs 80.5 bn12.35
HINOON976.8463%Rs 51.8 bn12.58
SEARL79.6910%Rs 46.9 bn12.06
AGP151.655%Rs 42.5 bn23.73
HPL4,000.0020%Rs 38.6 bn11.04
FEROZ (this company)350.9532%Rs 15.3 bn22.18
CPHL62.1812%Rs 14.2 bn17.47
BFBIO137.2233%Rs 12.1 bn18.44
MACTER49.6719%Rs 11.4 bn3.55

Place in the range: 0% is the 52-week low and 100% the high, on closes adjusted for splits and bonus issues. The other companies are those in the same PSX sector that traded in the last 10 sessions. A sector median needs 1 or more companies. As of 20 Nov 2026.

Returns against the index and the sector

FEROZ return with dividends by window

Return with dividends, not reinvested, over each window; the KSE-100 tick reinvests dividends too. Source: PSX closes, as of 20 Nov 2026.
WindowFEROZ priceFEROZ with dividendsKSE-100Sector median
1 month+6.10%+6.10%+7.41%+3.24%10 companies
3 months-1.35%+0.20%+0.45%-4.13%10 companies
6 months-2.59%-1.06%+7.61%-4.13%10 companies
Since 1 January-6.60%-5.13%+1.91%-16.14%10 companies
1 year-12.04%-10.67%+8.87%-15.80%10 companies
3 years+65.84%+71.75%+210.77%+147.08%9 companies
5 years-6.01%-1.33%+281.55%+74.12%9 companies

Price only: closes adjusted for bonus and rights issues, to the latest price. With dividends: adds cash dividends, not reinvested. The KSE-100 figure reinvests dividends. Source: PSX closes and payout notices.

More on FEROZ

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .